 |
|
Trends in Dermatology: Melanoma Incidence
Darrell S. Rigel, MD
Arch Dermatol. 2010;146(3):318.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The incidence of invasive melanoma in the United States continues to rise 4% to 6% annually despite all of our efforts to improve primary prevention. Similar increases are being noted worldwide. It was estimated that 68 720 Americans will have been diagnosed as having melanoma in 2009, and the current lifetime risk for developing invasive melanoma is 1 in 58.1 When the estimated 53 120 cases of in situ melanoma are added, the lifetime risk for being diagnosed as having melanoma is now 1 in 30. Also, it was estimated that 8650 Americans died of melanoma in 2009.
This increase in melanoma incidence is not due to artifact and cannot be attributable to better counting methods (many cancers are decreasing) or to changes in histologic diagnosis (longitudinal studies have shown no temporal change).2 Actual rates are probably higher than reported because most tumors are treated in the outpatient . . . [Full Text of this Article]
Dr Rigel is with the Department of Dermatology, New York University, New York, New York (dsrigel@prodigy.net).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Therapeutic options in cutaneous melanoma: latest developments
Amaria et al.
Therapeutic Advances in Medical Oncology 2011;3:245-251.
ABSTRACT
A curated online resource for SOX10 and pigment cell molecular genetic pathways
Baxter et al.
Database 2010;2010:baq025-baq025.
ABSTRACT
| FULL TEXT
|
